Associate Professor in Pediatrics, Northwestern University Medical School
Pediatric Hematology & Oncology
Dr. Reggie E. Duerst, MD
|
|
Give Review
Dr. Reggie E. Duerst works in the field of Pediatric Hematology & Oncology. He went to University of Wisconsin School of Medicine and Public Health. Reggie Duerst is also published. He has 49 publications published. The lastest publication: "Autotransplantation for relapsed or refractory Hodgkin''s disease: long-term follow-up and analysis of prognostic factors.'
Publications
- Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita.
- Tandem high-dose chemotherapy with autologous peripheral hematopoietic progenitor cell rescue as consolidation therapy for patients with high-risk Ewing family tumors.
- Favorable outcome for infant Acute lymphoblastic leukemia after hematopoietic stem cell transplantation.
- A new complication of stem cell transplantation: measles inclusion body encephalitis.
- Nonoperative management of pneumatosis intestinalis and pneumoperitoneum in a patient with Acute lymphoblastic leukemia: case report and review of the literature.
- Safety and efficacy of allogeneic PBSC collection in normal pediatric donors: the pediatric blood and marrow transplant consortium experience (PBMTC) 1996-2003.
- Analysis of factors that correlate with mucositis in recipients of autologous and allogeneic stem-cell transplants.
- Cells of the J774 macrophage cell line are primed for antibody-dependent cell-mediated cytotoxicity following exposure to gamma-irradiation.
- Continuous infusion cyclosporine and nifedipine to day +100 with short methotrexate and steroids as GVHD prophylaxis in unrelated donor transplants.
- Wilms'' tumor 1 (WT1) gene in hematopoiesis: a surrogate marker of cell proliferation as a possible mechanism of action?
- Developing a pediatric outpatient transplantation program. The Children's Memorial Hospital experience.
- Outcomes of unrelated cord blood transplants and allogeneic-related hematopoietic stem cell transplants in children with high-risk Acute lymphocytic leukemia.
- Weight loss and reduced body mass index: a critical issue in children with multiorgan chronic Graft-versus-host disease.
- Age-dependent pharmacokinetic profile of single daily dose i.v. busulfan in children undergoing reduced-intensity conditioning stem cell transplant.
- Reduced-intensity conditioning regimens for allogeneic transplantation in children with Acute lymphoblastic leukemia.
- Early elevation of C-reactive protein correlates with severe infection and nonrelapse mortality in children undergoing allogeneic stem cell transplantation.
- A phase II prospective study of sequential myeloablative chemotherapy with hematopoietic stem cell rescue for the treatment of selected high risk and recurrent central...
- High WT1 gene expression before haematopoietic stem cell transplant in children with Acute myeloid leukaemia predicts poor event-free survival.
- Dose intensive melphalan and cyclophosphamide with autologous hematopoietic stem cells for recurrent Medulloblastoma or germinoma.
- Mycoplasma pneumoniae and atypical Stevens-Johnson syndrome in a hematopoietic stem cell transplant recipient.
- Reduced intensity transplants (RIT) in pediatrics: a review.
- Hepatitic pattern of Graft versus host disease in children.
- Pharmacokinetics of a test dose of intravenous busulfan guide dose modifications to achieve an optimal area under the curve of a single daily dose of intravenous busul...
- Treatment of relapsed Wilms' tumor with high-dose therapy and autologous hematopoietic stem-cell rescue: the experience at Children's Memorial Hospital.
- Reduced intensity haemopoietic stem-cell transplantation for treatment of non-malignant Diseases in children.
- Eosinophilia correlates with the presence or development of chronic Graft-versus-host disease in children.
- Nonmyeloablative hematopoietic stem cell transplant for X-linked hyper-immunoglobulin m syndrome with cholangiopathy.
- Bone marrow necrosis associated with relapse of Acute myelogenous leukemia following unrelated hematopoeitic stem cell transplantation using an immunoablative regimen.
- Autotransplantation for relapsed or refractory Hodgkin''s Disease: long-term follow-up and analysis of prognostic factors.
- A Phase I study of human gamma interferon gene-transduced tumor cells in patients with neuroblastoma.
- Autotransplantation for relapsed or refractory non-Hodgkin''s lymphoma (NHL): long-term follow-up and analysis of prognostic factors.
- Patients > or = age 40 years undergoing autologous or allogeneic BMT have regimen-related mortality rates and event-free survivals comparable to patients < age 40 years.
- A sensitive assay of cytotoxicity applicable to mixed cell populations.
- Anti-neuroblastoma monoclonal antibodies which do not bind to bone marrow cells.
- Lysis of human fibroblast colony-forming cells and endothelial cells by monoclonal antibody (6-19) and complement.
- Variables affecting the killing of cultured human neuroblastoma cells with monoclonal antibody and complement.
- A monoclonal anti-neuroblastoma antibody that discriminates between human nonhematopoietic and hematopoietic cell types.
- Sensitive detection of rare metastatic human neuroblastoma cells in bone marrow by two-color immunofluorescence and cell sorting.
- Characterization of human marrow stromal cells: role in progenitor cell binding and granulopoiesis.
- Pathogenesis of vertebral metastasis and epidural spinal cord compression.
- Vascular anatomy and organ-specific tumor growth as critical factors in the development of metastases and their distribution among organs.
- Complement depletion in vitro limits monoclonal antibody 6-19-dependent complement-mediated killing of tumor cells in bone marrow.
- Allogeneic bone marrow transplantation for children with Acute leukemia: cytoreduction with fractionated total body irradiation, high-dose etoposide and cyclophosphamide.
- Treatment of chronic myelogenous Leukemia with autologous bone marrow transplantation followed by roquinimex.
- An 80,000-kd glycoprotein cell surface antigen found only on nonhematopoietic cells in human bone marrow.
- Cytokine effects and role of adhesive proteins and Fc receptors in human macrophage-mediated antibody dependent cellular cytotoxicity.
- Challenges in the use of allogeneic hematopoietic SCT for ectodermal dysplasia with immune deficiency.
- Allogeneic hematopoetic stem cell transplantation in pediatric myelodysplastic syndromes: improved outcomes for de novo Disease.
Schools
University Of Wisconsin Medical School
Strong Memorial Hospital
Conditions Treated
- Acute Leukemia
- Anemia
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- Brain Cancer
- View All
Doctors Specialties
- Pediatric Hematology
- Oncology
Accepted Insurances
Education
-
University of Rochester -
University of Wisconsin School of Medicine and Public Health
Hospital
-
Lurie Children's Hospital of Chicago -
Northwestern Memorial Hospital -
Ann & Robert H. Lurie Children?
Helpful Reviews
Similar Doctors
|
|
Dr. Susan L. Cohn, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Morris Kletzel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert I. Liem VIII, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William T. Tse, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nupur Mittal, MD
This Doctor is OpenDoctor Recommended.
|